Lei ZN - Search Results

1

Structure-Based Design, Synthesis, and Biological Evaluation of New Triazolo[1,5-a]Pyrimidine Derivatives as Highly Potent and Orally Active ABCB1 Modulators.

Wang S, Wang SQ, Teng QX, Yang L, Lei ZN, Yuan XH, Huo JF, Chen XB, Wang M, Yu B, Chen ZS, Liu HM. Wang S, et al. Among authors: lei zn. J Med Chem. 2020 Dec 24;63(24):15979-15996. doi: 10.1021/acs.jmedchem.0c01741. Epub 2020 Dec 5. J Med Chem. 2020. PMID: 33280384

2

Establishment and characterization of arsenic trioxide resistant KB/ATO cells.

Zhang YK, Dai C, Yuan CG, Wu HC, Xiao Z, Lei ZN, Yang DH, Le XC, Fu L, Chen ZS. Zhang YK, et al. Among authors: lei zn. Acta Pharm Sin B. 2017 Sep;7(5):564-570. doi: 10.1016/j.apsb.2017.04.001. Epub 2017 Apr 28. Acta Pharm Sin B. 2017. PMID: 28924550 Free PMC article.

3

Design, synthesis and biological evaluation of WZ4002 analogues as EGFR inhibitors.

Romu AA, Lei Z, Zhou B, Chen ZS, Korlipara V. Romu AA, et al. Bioorg Med Chem Lett. 2017 Nov 1;27(21):4832-4837. doi: 10.1016/j.bmcl.2017.09.048. Epub 2017 Sep 25. Bioorg Med Chem Lett. 2017. PMID: 28974338

4

Cytotoxic and acute toxicity studies of isoniazid derivatives.

Naeem S, Akhtar S, Lei ZN, Lu K, Zafar S, Ahmed A, Ali M, Ahmed M, Chen ZS. Naeem S, et al. Among authors: lei zn. Pak J Pharm Sci. 2017 Nov;30(6(Supplementary)):2411-2415. Pak J Pharm Sci. 2017. PMID: 29188778

5

Dacomitinib antagonizes multidrug resistance (MDR) in cancer cells by inhibiting the efflux activity of ABCB1 and ABCG2 transporters.

Fan YF, Zhang W, Zeng L, Lei ZN, Cai CY, Gupta P, Yang DH, Cui Q, Qin ZD, Chen ZS, Trombetta LD. Fan YF, et al. Among authors: lei zn. Cancer Lett. 2018 May 1;421:186-198. doi: 10.1016/j.canlet.2018.01.021. Epub 2018 Jan 11. Cancer Lett. 2018. PMID: 29331420

6

Synthesis and biological evaluation of indole-based UC-112 analogs as potent and selective survivin inhibitors.

Wang Q, Arnst KE, Xue Y, Lei ZN, Ma D, Chen ZS, Miller DD, Li W. Wang Q, et al. Among authors: lei zn. Eur J Med Chem. 2018 Apr 10;149:211-224. doi: 10.1016/j.ejmech.2018.02.045. Epub 2018 Feb 19. Eur J Med Chem. 2018. PMID: 29501942 Free PMC article.

7

Discovery of 5-Cyano-6-phenylpyrimidin Derivatives Containing an Acylurea Moiety as Orally Bioavailable Reversal Agents against P-Glycoprotein-Mediated Mutidrug Resistance.

Wang B, Ma LY, Wang JQ, Lei ZN, Gupta P, Zhao YD, Li ZH, Liu Y, Zhang XH, Li YN, Zhao B, Chen ZS, Liu HM. Wang B, et al. Among authors: lei zn. J Med Chem. 2018 Jul 26;61(14):5988-6001. doi: 10.1021/acs.jmedchem.8b00335. Epub 2018 Jul 18. J Med Chem. 2018. PMID: 29975529

8

Design, synthesis and biological evaluation of selective survivin inhibitors.

Xiao M, Xue Y, Wu Z, Lei ZN, Wang J, Chen ZS, Li W. Xiao M, et al. Among authors: lei zn. J Biomed Res. 2019 Apr 22;33(2):82-100. doi: 10.7555/JBR.31.20160173. J Biomed Res. 2019. PMID: 30174320 Free PMC article.

9

Selonsertib (GS-4997), an ASK1 inhibitor, antagonizes multidrug resistance in ABCB1- and ABCG2-overexpressing cancer cells.

Ji N, Yang Y, Cai CY, Lei ZN, Wang JQ, Gupta P, Shukla S, Ambudkar SV, Kong D, Chen ZS. Ji N, et al. Among authors: lei zn. Cancer Lett. 2019 Jan;440-441:82-93. doi: 10.1016/j.canlet.2018.10.007. Epub 2018 Oct 10. Cancer Lett. 2019. PMID: 30315846 Free PMC article.

10

Olmutinib (BI1482694/HM61713), a Novel Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, Reverses ABCG2-Mediated Multidrug Resistance in Cancer Cells.

Zhang W, Fan YF, Cai CY, Wang JQ, Teng QX, Lei ZN, Zeng L, Gupta P, Chen ZS. Zhang W, et al. Among authors: lei zn. Front Pharmacol. 2018 Oct 9;9:1097. doi: 10.3389/fphar.2018.01097. eCollection 2018. Front Pharmacol. 2018. PMID: 30356705 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

76 results

Search Page

Filters